2024-06-04
Beimei Pharmaceutical production base (Beimei Pharmaceutical wholly-owned subsidiary - Jiangsu Beimei Pharmaceutical Co., Ltd.) was successfully settled in Lianyungang Free Trade Zone， International Pharmaceutical Innovation Industrial Park
More +2024-06-04
Obtained Certificate of Intellectual Property Management System Certification
2024-06-04
Obtained Certificate of Intellectual Property Management System Certification
2024-06-04
Beimei (Shenzhen) Innovation Centreput into service
2024-06-04
Beimei (Shenzhen) Innovation Centreput into service
2024-06-04
Oselavir®(Oseltamivir Phosphate for Suspension) successfully wonin the eighth roundof National Pharmaceutical VBP
2024-06-04
Oselavir®(Oseltamivir Phosphate for Suspension) successfully wonin the eighth roundof National Pharmaceutical VBP
2024-06-04
Awarded with the title of Shenzhen Innovation-driven SME Enterprise
2024-06-04
Awarded with the title of Shenzhen Innovation-driven SME Enterprise
2024-06-04
PRESOMID®(Esomeprazole Magnesium for Delayed-Release Oral Suspension) approved for marketing
2024-06-04
PRESOMID®(Esomeprazole Magnesium for Delayed-Release Oral Suspension) approved for marketing
2024-06-04
Passed the certificationof National High-tech Enterprise
2024-06-04
Passed the certificationof National High-tech Enterprise
2024-06-04
Signed up an exclusive license and supply agreement in China with SyriMed, UKfor a children's skeletal muscle relaxation oral solution
2024-06-04
Signed up an exclusive license and supply agreement in China with SyriMed, UKfor a children's skeletal muscle relaxation oral solution
2024-06-04
Signed up an exclusive license and supply agreement in China with Ciplafor one newborn-specific product
2024-06-04
Signed up an exclusive license and supply agreement in China with Ciplafor one newborn-specific product
2024-06-04
New office (2000m2) of the Shenzhen headquartersputinto service
2024-06-04
New office (2000m2) of the Shenzhen headquartersputinto service
